FindTrial
Sign In

Multicenter and prospective study of chemotherapy associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens

Multicenter and prospective study of chemotherapy associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-14005147
Enrollment
Unknown
Registered
2014-06-17
Start date
2010-08-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

case series:six commonly used regimens (i.e. CF/XP
EC(O)F/EC(O)X
DC(O)F/DC(O)X
PC(O)F/PC(O)X
FOLFOX4
mFOLFOX7/XELOX)

Sponsors

Gastrointestinal Oncology Department, Affiliated Cancer Center of Academy of Military Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: Patients eligible for assessment were those of aged older than 18, pathologically confirmed as gastric cancer and being treated with at least 3 cycles for regimen CF/XP; EC(O)F/EC(O)X; DC(O)F/DC(O)X; PC(O)F/PC(O)X; 4 cycles for FOLFOX4 and more than 6 cycles for mFOLFOX7/XELOX, regardless of stage and prior treatment history.

Exclusion criteria

Exclusion criteria: Patients who does not meet with the criteria were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Hemoglobin;Platelet;Absolute neutrophil count;White blood count;—

Countries

China

Contacts

Public ContactXu Jianming
jmxu2003@yahoo.com+86 13910866712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026